サインイン 無料でサインアップします。

Accelerate Diagnostics Incの推定成長EPS Q/Q

Accelerate Diagnostics Incの推定成長EPS Q/Qは何ですか。

Accelerate Diagnostics Incの推定成長EPS Q/Qは26.67%です。

推定成長EPS Q/Qの定義は何ですか。



期待される四半期ごとのEPS成長率は、過去四半期の業績と比較して、次の四半期の企業EPSの推定増加です。

The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

NASDAQのセクタHealth Careにおける推定成長EPS Q/Qの企業と比べるAccelerate Diagnostics Inc

Accelerate Diagnostics Incは何をしますか。

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

Accelerate Diagnostics Incと類似の推定成長eps q/q